10 articles tagged
Nvidia's stock rose on a new AI deal, while Biohaven shares fell sharply after its depression drug trial missed its main goal. Sidus Space rallied on plans for a public offering.
Two Georgia Tech graduates have developed a new at-home health monitoring system inspired by NASA technology, using urine samples to track stress and recovery.
Cambridge's biotech lab space vacancy rate has soared to 22%, a dramatic shift from near-zero availability four years ago, impacting rents and development.
The UK Space Agency is funding biotech startup LinkGevity to test an anti-aging therapeutic in space, aiming to accelerate research for diseases on Earth.
The space medicine market is projected to grow to $2.14 billion by 2029, driven by increased space tourism and longer missions, according to a new report.
NASA's Artemis II mission will feature a pioneering experiment using 'organ-on-a-chip' technology to study the effects of deep space on astronaut health.
UK space startup Frontier Space is planning a new mission for 2026 after its first flight validated its core tech but failed to return key biological data.
NASA will send personalized bone marrow organ chips on the Artemis II mission to study the effects of deep space radiation and microgravity on astronaut health.
AbbVie's $1.2 billion deal for a depression asset is signaling a major shift, with large pharmaceutical firms now seriously eyeing the psychedelic therapeutics market.
A new survey finds only 15% of Americans are confident in U.S. AI leadership, while biotech firm Colossal Biosciences makes a major breakthrough in reviving the dodo.
